{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:24:21Z","timestamp":1790018661709,"version":"4.0.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP16K10596"],"award-info":[{"award-number":["JP16K10596"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP21K07219"],"award-info":[{"award-number":["JP21K07219"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP16H05416"],"award-info":[{"award-number":["JP16H05416"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP19H03731"],"award-info":[{"award-number":["JP19H03731"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["17ck0106285h0001"],"award-info":[{"award-number":["17ck0106285h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["20ck0106569h0001"],"award-info":[{"award-number":["20ck0106569h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pancreatic ductal adenocarcinoma (PDAC)-associated pancreatic stellate cells (PSCs) promote PDAC tumor progression. Notably, PDAC tumors display enhanced macropinocytosis, resulting in enhanced uptake of extracellular particles, including nutrients and viruses. We previously demonstrated the therapeutic potential of telomerase-specific oncolytic adenoviruses OBP-301 and p53-armed OBP-702 against human PDAC cells. However, it remains unclear whether macropinocytosis promotes the virus sensitivity of PDAC-associated PSCs. Here, we show that PSCs activated by human PDAC cells (Panc-1 and BxPC-3) exhibit enhanced sensitivity to wild-type and oncolytic adenoviruses via enhanced macropinocytosis. The virus sensitivity of PSCs was analyzed for the infectivity, replication, and cytopathic activity of wild-type and oncolytic adenoviruses. PDAC-associated PSCs were more sensitive to wild-type and oncolytic adenoviruses than were control PSCs; this sensitivity was mediated by activation of macropinocytosis. In three-dimensional (3D) culture models, p53-armed OBP-702 decreased the viability of PDAC-associated PSCs more strongly than did non-armed OBP-301, reflecting induction of p53-mediated apoptosis. Co-inoculation of PSCs enhanced the growth of PDAC tumors, an effect that was attenuated by OBP-702-mediated p53 activation in the tumor stroma. Our results suggest that p53-armed oncolytic adenovirus OBP-702 eliminates PDAC-associated PSCs via enhancement of macropinocytosis-mediated virus entry and induction of p53-mediated apoptosis.<\/jats:p>","DOI":"10.1038\/s41417-025-00989-3","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T05:02:50Z","timestamp":1764306170000},"page":"223-235","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["p53-armed oncolytic adenovirus induces apoptosis in pancreatic cancer-associated stellate cells via macropinocytosis"],"prefix":"10.1038","volume":"33","author":[{"given":"Takeyoshi","family":"Nishiyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4658-1050","authenticated-orcid":false,"given":"Hiroshi","family":"Tazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryohei","family":"Shoji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Kajiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9592-9209","authenticated-orcid":false,"given":"Naoyuki","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Ohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5584-3908","authenticated-orcid":false,"given":"Kazuhiro","family":"Noma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuichi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzo","family":"Umeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1494-7716","authenticated-orcid":false,"given":"Hiroyoshi Y.","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsunobu R.","family":"Kano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Masamune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Urata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3610-8211","authenticated-orcid":false,"given":"Shunsuke","family":"Kagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5377-6051","authenticated-orcid":false,"given":"Toshiyoshi","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"key":"989_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14740\/wjon1166","volume":"10","author":"P Rawla","year":"2019","unstructured":"Rawla P, Sunkara T, Gaduputi V. Epidemiology of pancreatic cancer: global trends, etiology and risk factors. World J Oncol. 2019;10:10\u201327.","journal-title":"World J Oncol"},{"key":"989_CR2","doi-asserted-by":"crossref","unstructured":"Deng D, Patel R, Chiang CY, Hou P. Role of the tumor microenvironment in regulating pancreatic cancer therapy resistance. Cells. 2022;11:2952.","DOI":"10.3390\/cells11192952"},{"key":"989_CR3","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41575-020-0300-1","volume":"17","author":"AN Hosein","year":"2020","unstructured":"Hosein AN, Brekken RA, Maitra A. Pancreatic cancer stroma: an update on therapeutic targeting strategies. Nat Rev Gastroenterol Hepatol. 2020;17:487\u2013505.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"989_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05351-1","volume":"13","author":"T Zhang","year":"2022","unstructured":"Zhang T, Ren Y, Yang P, Wang J, Zhou H. Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma. Cell Death Dis. 2022;13:897.","journal-title":"Cell Death Dis"},{"key":"989_CR5","doi-asserted-by":"crossref","unstructured":"Brichkina A, Polo P, Sharma SD, Visestamkul N, Lauth M. A quick guide to CAF subtypes in pancreatic cancer. Cancers. 2023;15:2614.","DOI":"10.3390\/cancers15092614"},{"key":"989_CR6","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3389\/fendo.2017.00261","volume":"8","author":"MV Recouvreux","year":"2017","unstructured":"Recouvreux MV, Commisso C. Macropinocytosis: a metabolic adaptation to nutrient stress in cancer. Front Endocrinol. 2017;8:261.","journal-title":"Front Endocrinol"},{"key":"989_CR7","doi-asserted-by":"crossref","unstructured":"Lin XP, Mintern JD, Gleeson PA. Macropinocytosis in different cell types: similarities and differences. Membranes. 2020;10:177.","DOI":"10.3390\/membranes10080177"},{"key":"989_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111798","volume":"141","author":"X Hao","year":"2021","unstructured":"Hao X, Ren Y, Feng M, Wang Q, Wang Y. Metabolic reprogramming due to hypoxia in pancreatic cancer: Implications for tumor formation, immunity, and more. Biomed Pharmacother. 2021;141:111798.","journal-title":"Biomed Pharmacother"},{"key":"989_CR9","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1158\/0008-5472.CAN-14-2211","volume":"75","author":"JJ Kamphorst","year":"2015","unstructured":"Kamphorst JJ, Nofal M, Commisso C, Hackett SR, Lu W, Grabocka E, et al. Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein. Cancer Res. 2015;75:544\u201353.","journal-title":"Cancer Res"},{"key":"989_CR10","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nature12138","volume":"497","author":"C Commisso","year":"2013","unstructured":"Commisso C, Davidson SM, Soydaner-Azeloglu RG, Parker SJ, Kamphorst JJ, Hackett S, et al. Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells. Nature. 2013;497:633\u20137.","journal-title":"Nature"},{"key":"989_CR11","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41586-019-1831-x","volume":"576","author":"C Ramirez","year":"2019","unstructured":"Ramirez C, Hauser AD, Vucic EA, Bar-Sagi D. Plasma membrane V-ATPase controls oncogenic RAS-induced macropinocytosis. Nature. 2019;576:477\u2013481.","journal-title":"Nature"},{"key":"989_CR12","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1158\/2159-8290.CD-20-0119","volume":"11","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Recouvreux MV, Jung M, Galenkamp KMO, Li Y, Zagnitko O, et al. Macropinocytosis in cancer-associated fibroblasts is dependent on CaMKK2\/ARHGEF2 signaling and functions to support tumor and stromal cell fitness. Cancer Discov. 2021;11:1808\u20131825.","journal-title":"Cancer Discov"},{"key":"989_CR13","doi-asserted-by":"crossref","unstructured":"Mantwill K, Klein FG, Wang D, Hindupur SV, Ehrenfeld M, Holm PS, et al. Concepts in oncolytic adenovirus therapy. Int J Mol Sci. 2021;22:10522.","DOI":"10.3390\/ijms221910522"},{"key":"989_CR14","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1158\/1078-0432.CCR-1075-3","volume":"10","author":"T Kawashima","year":"2004","unstructured":"Kawashima T, Kagawa S, Kobayashi N, Shirakiya Y, Umeoka T, Teraishi F, et al. Telomerase-specific replication-selective virotherapy for human cancer. Clin Cancer Res. 2004;10:285\u201392.","journal-title":"Clin Cancer Res"},{"key":"989_CR15","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/j.1349-7006.2007.00665.x","volume":"99","author":"Y Hashimoto","year":"2008","unstructured":"Hashimoto Y, Watanabe Y, Shirakiya Y, Uno F, Kagawa S, Kawamura H, et al. Establishment of biological and pharmacokinetic assays of telomerase-specific replication-selective adenovirus. Cancer Sci. 2008;99:385\u201390.","journal-title":"Cancer Sci"},{"key":"989_CR16","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1158\/1078-0432.CCR-10-2066","volume":"17","author":"T Sasaki","year":"2011","unstructured":"Sasaki T, Tazawa H, Hasei J, Kunisada T, Yoshida A, Hashimoto Y, et al. Preclinical evaluation of telomerase-specific oncolytic virotherapy for human bone and soft tissue sarcomas. Clin Cancer Res. 2011;17:1828\u201338.","journal-title":"Clin Cancer Res"},{"key":"989_CR17","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1016\/j.ejca.2011.12.020","volume":"48","author":"Y Yamasaki","year":"2012","unstructured":"Yamasaki Y, Tazawa H, Hashimoto Y, Kojima T, Kuroda S, Yano S, et al. A novel apoptotic mechanism of genetically engineered adenovirus-mediated tumour-specific p53 overexpression through E1A-dependent p21 and MDM2 suppression. Eur J Cancer. 2012;48:2282\u201391.","journal-title":"Eur J Cancer"},{"key":"989_CR18","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1158\/1535-7163.MCT-12-0869","volume":"12","author":"J Hasei","year":"2013","unstructured":"Hasei J, Sasaki T, Tazawa H, Osaki S, Yamakawa Y, Kunisada T, et al. Dual programmed cell death pathways induced by p53 transactivation overcome resistance to oncolytic adenovirus in human osteosarcoma cells. Mol Cancer Ther. 2013;12:314\u201325.","journal-title":"Mol Cancer Ther"},{"key":"989_CR19","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.omto.2020.03.016","volume":"17","author":"T Koujima","year":"2020","unstructured":"Koujima T, Tazawa H, Ieda T, Araki H, Fushimi T, Shoji R, et al. Oncolytic virus-mediated targeting of the ERK signaling pathway inhibits invasive propensity in human pancreatic cancer. Mol Ther Oncolytics. 2020;17:107\u2013117.","journal-title":"Mol Ther Oncolytics"},{"key":"989_CR20","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/jgm.409","volume":"5","author":"O Meier","year":"2003","unstructured":"Meier O, Greber UF. Adenovirus endocytosis. J Gene Med. 2003;5:451\u201362.","journal-title":"J Gene Med"},{"key":"989_CR21","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/ncb0509-510","volume":"11","author":"J Mercer","year":"2009","unstructured":"Mercer J, Helenius A. Virus entry by macropinocytosis. Nat Cell Biol. 2009;11:510\u201320.","journal-title":"Nat Cell Biol"},{"key":"989_CR22","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/nm1404","volume":"12","author":"H Kishimoto","year":"2006","unstructured":"Kishimoto H, Kojima T, Watanabe Y, Kagawa S, Fujiwara T, Uno F, et al. In vivo imaging of lymph node metastasis with telomerase-specific replication-selective adenovirus. Nat Med. 2006;12:1213\u20139.","journal-title":"Nat Med"},{"key":"989_CR23","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nprot.2014.004","volume":"9","author":"C Commisso","year":"2014","unstructured":"Commisso C, Flinn RJ, Bar-Sagi D. Determining the macropinocytic index of cells through a quantitative image-based assay. Nat Protoc. 2014;9:182\u201392.","journal-title":"Nat Protoc"},{"key":"989_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.120077","volume":"251","author":"HY Tanaka","year":"2020","unstructured":"Tanaka HY, Kurihara T, Nakazawa T, Matsusaki M, Masamune A, Kano MR. Heterotypic 3D pancreatic cancer model with tunable proportion of fibrotic elements. Biomaterials. 2020;251:120077.","journal-title":"Biomaterials"},{"key":"989_CR25","doi-asserted-by":"publisher","first-page":"4049","DOI":"10.1128\/JVI.72.5.4049-4056.1998","volume":"72","author":"SP Fessler","year":"1998","unstructured":"Fessler SP, Young CS. Control of adenovirus early gene expression during the late phase of infection. J Virol. 1998;72:4049\u201356.","journal-title":"J Virol"},{"key":"989_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1185093","volume":"13","author":"Z Wang","year":"2023","unstructured":"Wang Z, He R, Dong S, Zhou W. Pancreatic stellate cells in pancreatic cancer: as potential targets for future therapy. Front Oncol. 2023;13:1185093.","journal-title":"Front Oncol"},{"key":"989_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.919819","volume":"13","author":"Z Qiu","year":"2022","unstructured":"Qiu Z, Liu W, Zhu Q, Ke K, Zhu Q, Jin W, et al. The role and therapeutic potential of macropinocytosis in cancer. Front Pharm. 2022;13:919819.","journal-title":"Front Pharm"},{"key":"989_CR28","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.devcel.2019.05.043","volume":"50","author":"SW Lee","year":"2019","unstructured":"Lee SW, Zhang Y, Jung M, Cruz N, Alas B, Commisso C. EGFR-Pak signaling selectively regulates glutamine deprivation-induced macropinocytosis. Dev Cell. 2019;50:381\u2013392.e5.","journal-title":"Dev Cell"},{"key":"989_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-17748-1","volume":"12","author":"V Boker","year":"2022","unstructured":"Boker V, Haussler J, Baumann J, Sunami Y, Trojanowicz B, Harwardt B, et al. Analysis of genomic alterations in cancer associated human pancreatic stellate cells. Sci Rep. 2022;12:13532.","journal-title":"Sci Rep"},{"key":"989_CR30","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/onc.2008.445","volume":"28","author":"J Bar","year":"2009","unstructured":"Bar J, Feniger-Barish R, Lukashchuk N, Shaham H, Moskovits N, Goldfinger N, et al. Cancer cells suppress p53 in adjacent fibroblasts. Oncogene. 2009;28:933\u20136.","journal-title":"Oncogene"},{"key":"989_CR31","doi-asserted-by":"publisher","first-page":"6410","DOI":"10.1073\/pnas.1719076115","volume":"115","author":"S Arandkar","year":"2018","unstructured":"Arandkar S, Furth N, Elisha Y, Nataraj NB, van der Kuip H, Yarden Y, et al. Altered p53 functionality in cancer-associated fibroblasts contributes to their cancer-supporting features. Proc Natl Acad Sci USA. 2018;115:6410\u20136415.","journal-title":"Proc Natl Acad Sci USA"},{"key":"989_CR32","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.omto.2022.04.009","volume":"25","author":"T Ogawa","year":"2022","unstructured":"Ogawa T, Kikuchi S, Tabuchi M, Mitsui E, Une Y, Tazawa H, et al. Modulation of p53 expression in cancer-associated fibroblasts prevents peritoneal metastasis of gastric cancer. Mol Ther Oncolytics. 2022;25:249\u2013261.","journal-title":"Mol Ther Oncolytics"},{"key":"989_CR33","doi-asserted-by":"crossref","unstructured":"Saison-Ridinger M, DelGiorno KE, Zhang TJ, Kraus A, French R, Jaquish D, et al. Reprogramming pancreatic stellate cells via p53 activation: a putative target for pancreatic cancer therapy. PLoS ONE. 2017;12:e0189051.","DOI":"10.1371\/journal.pone.0189051"},{"key":"989_CR34","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.4103\/jcrt.jcrt_91_21","volume":"18","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Li Y, Chen K, Qian L, Wang P. Oncolytic virotherapy against the tumor microenvironment and its potential in pancreatic cancer. J Cancer Res Ther. 2022;18:1247\u20131255.","journal-title":"J Cancer Res Ther"},{"key":"989_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216456","volume":"579","author":"AR Yoon","year":"2023","unstructured":"Yoon AR, Hong J, Jung BK, Ahn HM, Zhang S, Yun CO. Oncolytic adenovirus as pancreatic cancer-targeted therapy: where do we go from here?. Cancer Lett. 2023;579:216456.","journal-title":"Cancer Lett"},{"key":"989_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.783617","volume":"9","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Zhang H, Liu T, Chen T, Wang D, Tang D. Heterogeneous pancreatic stellate cells are powerful contributors to the malignant progression of pancreatic cancer. Front Cell Dev Biol. 2021;9:783617.","journal-title":"Front Cell Dev Biol"},{"key":"989_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.omton.2024.200806","volume":"32","author":"M Tabuchi","year":"2024","unstructured":"Tabuchi M, Kikuchi S, Tazawa H, Okura T, Ogawa T, Mitsui E, et al. Functional remodeling of intraperitoneal macrophages by oncolytic adenovirus restores anti-tumor immunity for peritoneal metastasis of gastric cancer. Mol Ther Oncol. 2024;32:200806.","journal-title":"Mol Ther Oncol"},{"key":"989_CR38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.omto.2022.09.003","volume":"27","author":"H Araki","year":"2022","unstructured":"Araki H, Tazawa H, Kanaya N, Kajiwara Y, Yamada M, Hashimoto M, et al. Oncolytic virus-mediated p53 overexpression promotes immunogenic cell death and efficacy of PD-1 blockade in pancreatic cancer. Mol Ther Oncolytics. 2022;27:3\u201313.","journal-title":"Mol Ther Oncolytics"},{"key":"989_CR39","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1007\/s00262-022-03334-x","volume":"72","author":"Y Kajiwara","year":"2023","unstructured":"Kajiwara Y, Tazawa H, Yamada M, Kanaya N, Fushimi T, Kikuchi S, et al. Oncolytic virus-mediated reducing of myeloid-derived suppressor cells enhances the efficacy of PD-L1 blockade in gemcitabine-resistant pancreatic cancer. Cancer Immunol Immunother. 2023;72:1285\u20131300.","journal-title":"Cancer Immunol Immunother"},{"key":"989_CR40","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ejca.2021.04.043","volume":"153","author":"Y Shirakawa","year":"2021","unstructured":"Shirakawa Y, Tazawa H, Tanabe S, Kanaya N, Noma K, Koujima T, et al. Phase I dose-escalation study of endoscopic intratumoral injection of OBP-301 (Telomelysin) with radiotherapy in oesophageal cancer patients unfit for standard treatments. Eur J Cancer. 2021;153:98\u2013108.","journal-title":"Eur J Cancer"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41417-025-00989-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-025-00989-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-025-00989-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T23:02:57Z","timestamp":1771455777000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41417-025-00989-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["989"],"URL":"https:\/\/doi.org\/10.1038\/s41417-025-00989-3","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"11 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"YUr is the President & CEO of Oncolys BioPharma Inc. HT and TF are consultants of Oncolys BioPharma, Inc. The other authors have no potential conflicts of interest to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}